Episode 205: An ominous biotech deal, vaccines for kids, & 'breakthrough' devices
The Readout Loud
00:00
Revengens Checkmane Acquisition - What You Didn't Like and What You Don't
This week's episode features a guest appearance from byote. We also look at whether regenerons checkmane acquisition is a good thing or a bad thing for byote. Tell us what you like about thes weeks episode, what you didn't like, and your take on whether regenerons checksmane acquisition was a good thingor a bad thing in this week's podcast.
Transcript
Play full episode
